Eli Lilly and Company (NYSE: LLY) reported fourth quarter 2022 earnings results today. Revenue fell 9% year-over-year to $7.3 billion. Reported net income grew 12% to $1.93 billion, or $2.14 per share, compared to last year. Adjusted EPS dropped 4% to $2.09. For FY2023, the company expects revenue of $30.3-30.8 billion and adjusted EPS of $8.35-8.55. […]
Eli Lilly and Company (NYSE: LLY) reported fourth quarter 2022 earnings results today. Revenue fell 9% year-over-year to $7.3 billion. Reported net income grew 12% to $1.93 billion, or $2.14 per share, compared to last year. Adjusted EPS dropped 4% to $2.09. For FY2023, the company expects revenue of $30.3-30.8 billion and adjusted EPS of $8.35-8.55. […]
Eli Lilly and Company (NYSE: LLY) reported fourth quarter 2022 earnings results today.
Revenue fell 9% year-over-year to $7.3 billion.
Reported net income grew 12% to $1.93 billion, or $2.14 per share, compared to last year. Adjusted EPS dropped 4% to $2.09.
For FY2023, the company expects revenue of $30.3-30.8 billion and adjusted EPS of $8.35-8.55.
